NeurologyLive® Friday 5 — July 31, 2026

Welcome to NeurologyLive^®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

Click the read more or watch now buttons for more details and information about each highlight.

1: Potential of Culturally Tailored Lifestyle Interventions for Cognitive Health: Lucia Crivelli, PhD

In a recent interview at AAIC 2026, Lucia Crivelli, PhD, professor of neurosciences and head of neuropsychology at Fleni Institute in Buenos Aires, Argentina, discussed findings from the LatAm-FINGERS study that suggest structured, multidomain lifestyle interventions may offer meaningful cognitive benefits among older adults in Latin America. [WATCH TIME: 3 minutes]

2: Clinical Utility and Practical Challenges of OCT in the 2024 McDonald Criteria for MS: Rachel Kenney, PhD

In a recent interview at CMSC 2026, Rachel Kenney, PhD, assistant professor of neurology at NYU Grossman School of Medicine, talked about how optical coherence tomography contributes to the updated 2024 McDonald criteria for multiple sclerosis. [WATCH TIME: 4 minutes]

3: How Autopsy Research Is Shaping Understanding of Anti-Amyloid Therapies: Edward B. Lee, MD, PhD

In a recent interview at AAIC 2026, Edward B. Lee, MD, PhD, the Trojanowski Professor for Neurodegenerative Disease Research at the University of Pennsylvania, discusses how postmortem and longitudinal imaging findings provide new insights into the potential downstream effects of amyloid clearance on tau pathology and neurodegeneration in Alzheimer disease. [WATCH TIME: 3 Mintutes]

4: What Salanersen's FDA Breakthrough Designation Means for Spinal Muscular Atrophy

In recent Q&A, Stephanie Fradette, PhD, senior vice president and head of Rare Neurology Department Unit at Biogen, gave commentary on the FDA designation and long-term outlook for salanersen, an investigational antisense agent for spinal muscular atrophy.

5: Special Episode: Na Tosha, Gatson, MD, PhD, on Newly Launched Neuro-Oncology Column

In this special edition of Mind Moments, Na Tosha Gatson, MD, PhD, senior medical director of neuro-oncology and director of the Center for Neuro-Oncology at Indiana University School of Medicine, joins the podcast to discuss her career journey, philosophy of patient care, and the launch of The G.L.O.B., a new recurring NeurologyLive column dedicated to advancing health literacy in neuro-oncology.

Don’t have time to read or watch a full video interview? Click here to check out our shorts!